Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Anna Kryzhanivska"'
Autor:
Domenica Lorusso, Anna Kryzhanivska, Patricia Pautier, Dominique Berton, Nawel Bourayou, Laurence Gladieff, Christine Gennigens, Chuan Tian, Sulabha Ranganathan, Ignace Vergote
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundManagement of patients with recurrent endometrial cancer after failure on platinum-based therapy remains a clinical challenge. Retifanlimab (INCMGA00012) is an investigational humanized immunoglobulin G4 monoclonal antibody against programm
Autor:
Alexander Gozman, Sanatan Saraf, Iwona Lugowska, Tudor Ciuleanu, Fan Jin, Miguel Quintela-Fandino, Andrew F. Hill, Henry L. Gomez, Karina Vera, Michele Maio, Seock-Ah Im, Ozgur Ozyilkan, Razvan Cristescu, Serhii Lysenko, Michael Schenker, Timothy A. Yap, Ronnie Shapira-Frommer, Anna Kryzhanivska, Salomon M. Stemmer
Publikováno v:
Cancer Research. 81:CT178-CT178
Background: Poly-ADP-ribose polymerase (PARP) inhibition plus PD-(L)1 blockade has shown encouraging antitumor activity in patients (pts) with recurrent ovarian or breast cancer with BRCAm and in pts with recurrent ovarian cancer regardless of BRCAm
Autor:
Anna Kryzhanivska, Iryna Dyakiv
Publikováno v:
Archive of Clinical Medicine; Vol. 25 No. 1 (2019)
Архів клінічної медицини; Том 25 № 1 (2019)
Архів клінічної медицини; Том 25 № 1 (2019)
An important morphological criterion for the development of the degree of malignancy of breast cancer is the change in the structure of cell nuclei. At the same time, both the morphometric parameters of metachronous breast cancer and their connection